Ergomed (ERGO)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

850.00p
   
  • Change Today:
    -2.00p
  • 52 Week High: 858.00
  • 52 Week Low: 280.00
  • Currency: UK Pounds
  • Shares Issued: 48.72m
  • Volume: 23,006
  • Market Cap: £414.10m

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth
65.40% above the market average65.40% above the market average65.40% above the market average65.40% above the market average65.40% above the market average
37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average37.14% above the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
16.69% above the market average16.69% above the market average16.69% above the market average16.69% above the market average16.69% above the market average
23.53% below the sector average23.53% below the sector average23.53% below the sector average23.53% below the sector average23.53% below the sector average
Price Book Ratio
87.95% below the market average87.95% below the market average87.95% below the market average87.95% below the market average87.95% below the market average
52% below the sector average52% below the sector average52% below the sector average52% below the sector average52% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
3.65% above the market average3.65% above the market average3.65% above the market average3.65% above the market average3.65% above the market average
58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average58.62% above the sector average
Price Chg 3m
77.68% above the market average77.68% above the market average77.68% above the market average77.68% above the market average77.68% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
25.12% below the market average25.12% below the market average25.12% below the market average25.12% below the market average25.12% below the market average
32.14% above the sector average32.14% above the sector average32.14% above the sector average32.14% above the sector average32.14% above the sector average
Momentum 20
75.47% above the market average75.47% above the market average75.47% above the market average75.47% above the market average75.47% above the market average
89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
1.67% above the market average1.67% above the market average1.67% above the market average1.67% above the market average1.67% above the market average
43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average
ROCE
38.23% above the market average38.23% above the market average38.23% above the market average38.23% above the market average38.23% above the market average
22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average22.22% below the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
36.77% above the market average36.77% above the market average36.77% above the market average36.77% above the market average36.77% above the market average
54.72% above the sector average54.72% above the sector average54.72% above the sector average54.72% above the sector average54.72% above the sector average
Forecast EPS
28.74% above the market average28.74% above the market average28.74% above the market average28.74% above the market average28.74% above the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
16.88% above the market average16.88% above the market average16.88% above the market average16.88% above the market average16.88% above the market average
28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average
Operating Profit Loss
16.95% above the market average16.95% above the market average16.95% above the market average16.95% above the market average16.95% above the market average
59.26% above the sector average59.26% above the sector average59.26% above the sector average59.26% above the sector average59.26% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
7.58% above the market average7.58% above the market average7.58% above the market average7.58% above the market average7.58% above the market average
30.77% above the sector average30.77% above the sector average30.77% above the sector average30.77% above the sector average30.77% above the sector average
Cash
14.07% above the market average14.07% above the market average14.07% above the market average14.07% above the market average14.07% above the market average
30.77% above the sector average30.77% above the sector average30.77% above the sector average30.77% above the sector average30.77% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
29.96% above the market average29.96% above the market average29.96% above the market average29.96% above the market average29.96% above the market average
31.58% above the sector average31.58% above the sector average31.58% above the sector average31.58% above the sector average31.58% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
38.19% above the market average38.19% above the market average38.19% above the market average38.19% above the market average38.19% above the market average
Sector averageSector averageSector averageSector averageSector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Ergomed Market Data

Currency UK Pounds
Share Price 850.00p
Change Today -2.00p
% Change -0.23 %
52 Week High 858.00
52 Week Low 280.00
Volume 23,006
Shares Issued 48.72m
Market Cap £414.10m

Ergomed Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.82% below the market average86.82% below the market average86.82% below the market average86.82% below the market average86.82% below the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average
Price Trend
97.26% above the market average97.26% above the market average97.26% above the market average97.26% above the market average97.26% above the market average
89.66% above the sector average89.66% above the sector average89.66% above the sector average89.66% above the sector average89.66% above the sector average
Income Not Available
Growth
21.73% above the market average21.73% above the market average21.73% above the market average21.73% above the market average21.73% above the market average
29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average29.73% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Ergomed Dividends

No dividends found

Trades for 26-Nov-2020

Time Volume / Share Price
16:35 5 @ 850.00p
16:22 2,000 @ 852.00p
16:21 2,000 @ 852.00p
16:21 2,000 @ 852.00p
16:12 296 @ 852.00p

Ergomed Key Personnel

COO Lewis Cameron

Top of Page